Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.

J Thaler; W Hilbe; U Apfelbeck; W Linkesch; H Sill; H Seewann; J Pont; M Bernhart; M Stöger; H Niessner

doi:10.1016/s0145-2126(96)00084-7

Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.

Identifier:nobleid.org/w1/20260515/A2AB3A96

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A2AB3A96.svg?ark=w1%2F20260515%2FA2AB3A96)](https://nobleid.org/work/w1/20260515/A2AB3A96)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.

Identifier:nobleid.org/w1/20260515/A2AB3A96

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A2AB3A96.svg?ark=w1%2F20260515%2FA2AB3A96)](https://nobleid.org/work/w1/20260515/A2AB3A96)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work